financetom
Business
financetom
/
Business
/
What's Going On With Oklo Stock Tuesday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Oklo Stock Tuesday?
Oct 17, 2024 12:46 PM

Oklo Inc ( OKLO ) shares are trading higher on continued momentum from Monday’s Google ( GOOG ) nuclear deal. The company on Tuesday announced that the U.S. Department of Energy approved a design report for its Aurora fuel fabrication facility.

What Happened: Oklo ( OKLO ) and several nuclear stocks got a lift in afternoon trading Monday after Alphabet Inc ( GOOG ) announced plans to purchase power from small modular reactor developer Kairos Power.

Google ( GOOG ) said it expects to have its first reactor online by 2030, with more reactors expected to follow through 2035. The nuclear strategy from Google ( GOOG ) comes as big tech companies are increasingly turning to nuclear power to meet the rising energy demands of data centers related to the AI boom.

"We believe that nuclear energy has a critical role to play in supporting our clean growth and helping to deliver on the progress of AI," said Michael Terrell, senior director for energy and climate at Google ( GOOG ). 

"The grid needs these kinds of clean, reliable sources of energy that can support the build-out of these technologies. We feel like nuclear can play an important role in helping to meet our demand, and helping meet our demand cleanly, in a way that’s more around the clock."

Oklo ( OKLO ) shares closed Monday up nearly 10% after surging into the close. The stock continued moving higher after hours and has held onto some gains heading into Tuesday’s trading session.

See Also: Nvidia CEO Jensen Huang Backs Nuclear Energy To Power AI’s Future: 3 Stocks To Watch

Oklo ( OKLO ) on Tuesday announced that the U.S. Department of Energy (DOE) approved the Conceptual Safety Design Report for the Aurora Fuel Fabrication Facility at Idaho National Laboratory, a key milestone in Oklo’s advancement toward utilizing nuclear material to fuel its first commercial powerhouse.

Oklo ( OKLO ) said the facility will use high assay low enriched uranium that has been recovered from used Experimental Breeder Reactor-II fuel. 

“Oklo is uniquely positioned with a secured fuel supply, site use permit, significant regulatory traction, and supply chain development to support the first deployment of its Aurora powerhouse,”  said Jacob DeWitte, co-founder and CEO of Oklo ( OKLO ).

The next steps in the DOE’s comprehensive review process include the Preliminary Documented Safety Analysis before construction and the Documented Safety Analysis after construction and commissioning.

OKLO Price Action: Oklo ( OKLO ) shares were up 4.68% at $10.50 at the time of publication, according to Benzinga Pro.

This illustration was generated using artificial intelligence via Midjourney.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bunker Hill Mining Advances Construction of Namesake Project in Idaho
Bunker Hill Mining Advances Construction of Namesake Project in Idaho
Oct 17, 2024
08:32 AM EDT, 10/17/2024 (MT Newswires) -- Bunker Hill Mining ( BHLL ) said Thursday that it continues to advance the construction of its namesake project in Idaho's Silver Valley. Bunker Hill said it remains on track to complete construction and start production in the first half of 2025. We are pleased to report that the construction of the Silver...
AbbVie Gets FDA Approval for Advanced Parkinson's Disease Therapy
AbbVie Gets FDA Approval for Advanced Parkinson's Disease Therapy
Oct 17, 2024
08:32 AM EDT, 10/17/2024 (MT Newswires) -- AbbVie ( ABBV ) said Thursday that the US Food and Drug Administration approved Vyalev as a subcutaneous 24-hour infusion of levodopa-based therapy to treat motor fluctuations in adults with advanced Parkinson's disease. The approval was based on a phase 3 study, which showed that continuous subcutaneous infusion of Vyalev was more effective...
Kezar Life Sciences Rejects Concentra Biosciences Takeover Bid, Adopts Rights Plan
Kezar Life Sciences Rejects Concentra Biosciences Takeover Bid, Adopts Rights Plan
Oct 17, 2024
09:11 AM EDT, 10/17/2024 (MT Newswires) -- Kezar Life Sciences ( KZR ) said Thursday that its board of directors has unanimously rejected an unsolicited takeover bid from Concentra Biosciences saying it substantially undervalues the company. The company said Concentra Biosciences sought to acquire all of its outstanding common stock for $1.10 cash per share, as well as the possibility...
BRIEF-Carlisle Companies To Acquire Plasti-Fab, A Canadian Based Vertically Integrated Manufacturer Of Expanded Polystyrene Insulation Products
BRIEF-Carlisle Companies To Acquire Plasti-Fab, A Canadian Based Vertically Integrated Manufacturer Of Expanded Polystyrene Insulation Products
Oct 17, 2024
Oct 17 (Reuters) - Carlisle Companies Inc ( CSL ): * CARLISLE COMPANIES TO ACQUIRE PLASTI-FAB, A CANADIAN BASED VERTICALLY INTEGRATED MANUFACTURER OF EXPANDED POLYSTYRENE INSULATION PRODUCTS * CARLISLE COMPANIES INC ( CSL ) - TO PURCHASE PLASTI-FAB FOR $259.5 MILLION IN CASH * CARLISLE COMPANIES INC ( CSL ) - ACQUISITION TO ADD $0.30 ADJUSTED EPS IN 2025 Source...
Copyright 2023-2025 - www.financetom.com All Rights Reserved